YaoGeJu

Company directoryChina company filings

Hai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanized

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference a4379d427b

Complete CDE snapshot
2026/11/13 06:42
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/13 06:42.

Drug filings

8 acceptance records as first applicant, grouped into 7 source drug names. Source data as of 2026/11/13 06:42.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

复方醋酸钠葡萄糖注射液 · No verified English name 2 records · Latest accepted 2026/05/19

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601174Generic2026/05/19Hai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanized; Jiangsu Da Hong Ying Heng Shun Pharma Co., Ltd. romanizedCDE ↗
CYHS2601173Generic2026/05/19Hai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanized; Jiangsu Da Hong Ying Heng Shun Pharma Co., Ltd. romanizedCDE ↗
Multiple Electrolytes and Sodium Acetate Injection 1 records · Latest accepted 2025/12/25

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2504389Generic2025/12/25Hai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanized; Jiangsu Da Hong Ying Heng Shun Pharma Co., Ltd. romanizedCDE ↗
Erythromycin Lactobionate for Injection 1 records · Latest accepted 2025/02/13

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500734Generic2025/02/13Hai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanized; Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanizedCDE ↗
Flomoxef Sodium for Injection 1 records · Latest accepted 2025/02/08

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500630Generic2025/02/08Hai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanized; Zhejiang Hui Di Sen Pharma Co., Ltd. romanizedCDE ↗
维生素B6注射液 · No verified English name 1 records · Latest accepted 2025/02/07

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500618Generic2025/02/07Hai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanized; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanizedCDE ↗
Cimetidine Injection 1 records · Latest accepted 2024/11/06

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403778Generic2024/11/06Hai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanized; Shandong Wei Zhi Bai Ke Pharma Co., Ltd. romanizedCDE ↗
Potassium Aspartate Injection 1 records · Latest accepted 2024/07/16

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402191Generic2024/07/16Hai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanized; Zhi He (Shandong) Da Pharmaceutical Factory Co., Ltd. romanizedCDE ↗

Changes in the last 90 days

0 events from 2026/08/16 to 2026/11/13. CDE data as of 2026/11/13 06:42; NMPA data as of 2026/11/12 18:32.

This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/13 06:42.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
复方醋酸钠葡萄糖注射液 · No verified English name CYHS2601174Generic2026/05/19Hai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanized; Jiangsu Da Hong Ying Heng Shun Pharma Co., Ltd. romanizedCDE ↗
复方醋酸钠葡萄糖注射液 · No verified English name CYHS2601173Generic2026/05/19Hai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanized; Jiangsu Da Hong Ying Heng Shun Pharma Co., Ltd. romanizedCDE ↗
Multiple Electrolytes and Sodium Acetate Injection CYHS2504389Generic2025/12/25Hai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanized; Jiangsu Da Hong Ying Heng Shun Pharma Co., Ltd. romanizedCDE ↗
Erythromycin Lactobionate for Injection CYHS2500734Generic2025/02/13Hai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanized; Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanizedCDE ↗

Catalogue holder records

3 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/13 06:39. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Flomoxef Sodium for InjectionHai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanizedZhejiang Hui Di Sen Pharma Co., Ltd. romanized国药准字H202661242026/09/29Generic approved under the new chemical-drug registration classificationCDE ↗
维生素B6注射液 · No verified English nameHai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanizedHunan Sai Long Pharma (Changsha) Co., Ltd. romanized国药准字H202659812026/09/15Generic approved under the new chemical-drug registration classificationCDE ↗
Potassium Aspartate InjectionHai Tao Xin Yao Research and Development (Jiangsu) Co., Ltd. romanizedZhi He (Shandong) Da Pharmaceutical Factory Co., Ltd. romanized国药准字H202634832026/02/25Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/13 06:41.

NameCompany / applicantRegistration numberStatusSource update dateView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/13 06:42.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/13 06:42
Chemical-drug catalogue
Last successful update: 2026/11/13 06:39
Full API register
Last successful update: 2026/11/13 06:41
NMPA drug delivery notices
Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete

First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.